<?xml version="1.0" encoding="UTF-8"?>
<p>Two other components of typical mānuka oil, grandiflorone (MIC = up to 0.0032% or 32 μg/mL) and myrigalone A (MIC = 0.0064% or 64 μg/mL), have also been identified as active against vancomycin-resistant 
 <italic>Enterococcus faecalis</italic> (VRE) and methicillin-resistant 
 <italic>S. aureus</italic> (MRSA) and may therefore provide potential treatments for infection with these bacterial species [
 <xref rid="B45-pharmaceuticals-13-00343" ref-type="bibr">45</xref>]. 
</p>
